ICYMI: A New Medical Device Invented by a Patient will Help Prevent Tongue Biting During Seizures
source: pixabay.com

ICYMI: A New Medical Device Invented by a Patient will Help Prevent Tongue Biting During Seizures

By Natalie Homan from In The Cloud Copy It’s estimated that about 3.4 million Americans have epilepsy, one of many conditions that can cause seizures. Seizures occur when there is…

Continue Reading ICYMI: A New Medical Device Invented by a Patient will Help Prevent Tongue Biting During Seizures
Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment
source: pixabay.com

Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment

by Danielle Bradshaw from In The Cloud Copy A year-long study has shown that Tracleer greatly reduces the skin-related symptoms of scleroderma. The results also showed that although it helped…

Continue Reading Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment
RNA Therapy Holds Promise for Treating SMA and Other Rare Diseases
source: pixabay.com

RNA Therapy Holds Promise for Treating SMA and Other Rare Diseases

by Jodee Redmond from In the Cloud Copy   Emma Larson’s parents were not particularly concerned when their daughter wasn’t standing or walking by her first birthday. They figured that plenty of children had not reached…

Continue Reading RNA Therapy Holds Promise for Treating SMA and Other Rare Diseases
One Hundred Vaccines Against COVID-19 Are In Early Stages of Development, But Only a Few Will Survive
source: pixabay.com

One Hundred Vaccines Against COVID-19 Are In Early Stages of Development, But Only a Few Will Survive

A total of one hundred vaccines are being developed by researchers, drug manufacturers, and governments worldwide in an effort to stem the tide of the COVID-19 virus. Reuters Newswire reports…

Continue Reading One Hundred Vaccines Against COVID-19 Are In Early Stages of Development, But Only a Few Will Survive
PTC Therapeutics to Acquire Censa Pharmaceuticals, Developer of an Experimental Phenylketonuria Drug
source: pixabay.com

PTC Therapeutics to Acquire Censa Pharmaceuticals, Developer of an Experimental Phenylketonuria Drug

According to a story from Xconomy, the drug company PTC Therapeutics has come to an agreement that will allow it to acquire Censa Pharmaceuticals and its lead product candidate. This…

Continue Reading PTC Therapeutics to Acquire Censa Pharmaceuticals, Developer of an Experimental Phenylketonuria Drug

Researchers Add a Third Risk Factor To Alzheimer’s Disease That Affects the Blood Brain Barrier

It is acknowledged in the medical community that clumps of misfolded tau proteins and amyloid-β are markers of Alzheimer’s disease. The evidence presented in recent article in Nature, shows that…

Continue Reading Researchers Add a Third Risk Factor To Alzheimer’s Disease That Affects the Blood Brain Barrier
New Task Force Recommends Shared Decision-Making for Parents and Patients with Juvenile Idiopathic Arthritis
source: pixabay.com

New Task Force Recommends Shared Decision-Making for Parents and Patients with Juvenile Idiopathic Arthritis

  According to a recent article in BioMed Central, an international task force formed in 2018 created guidelines for the treatment of juvenile idiopathic arthritis (JIA). Treatment targets were identified…

Continue Reading New Task Force Recommends Shared Decision-Making for Parents and Patients with Juvenile Idiopathic Arthritis
ICYMI: First Drug to be Approved for Neurofibromatosis Type 1 and Plexiform Neurofibromas (NF1-PN)
source: pixabay.com

ICYMI: First Drug to be Approved for Neurofibromatosis Type 1 and Plexiform Neurofibromas (NF1-PN)

  According to a recent announcement by AstraZeneca, the U.S. FDA granted its approval for Koselugo (selumetinib). This is the first drug to be approved for the treatment of children…

Continue Reading ICYMI: First Drug to be Approved for Neurofibromatosis Type 1 and Plexiform Neurofibromas (NF1-PN)
Warrior Princess: Fighting a Rare Disease Under Unprecedented Circumstances, Part Two
source: pixabay.com

Warrior Princess: Fighting a Rare Disease Under Unprecedented Circumstances, Part Two

Continued From Part One written by Payel Bhattacharya Pharmaceutical science has medications to control the pain. I was initially put on medicine but it mostly didn’t contain the pain. I…

Continue Reading Warrior Princess: Fighting a Rare Disease Under Unprecedented Circumstances, Part Two

Metabolic Syndrome, Cause of Heart Disease and Diabetes, Linked To LRRK2 Mutations

Certain features of metabolic syndrome may be more prevalent in people with Parkinson’s disease-associated mutations in the gene LRRK2, new research suggests. The research abstract “Metabolic syndrome and genetic Parkinson’s disease, the case…

Continue Reading Metabolic Syndrome, Cause of Heart Disease and Diabetes, Linked To LRRK2 Mutations

New Study Offers Promising Results for Identifying the Cause and Finding Potential Treatments for Ulcerative Colitis 

By Natalie Homan from In the Cloud Copy What Is Ulcerative Colitis?  Ulcerative Colitis is a condition where the colon and rectum become inflamed and develop ulcers. It is a painful…

Continue Reading New Study Offers Promising Results for Identifying the Cause and Finding Potential Treatments for Ulcerative Colitis 
CRISPR and COVID-19: The Impact on Biotech
Sourced from NIH Image Gallery (Public Domain). Credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH

CRISPR and COVID-19: The Impact on Biotech

  Saying that COVID-19 has impacted the world might just be an understatement. In fact, COVID-19 changed the way we interact with each other, businesses, and the world around us. But how…

Continue Reading CRISPR and COVID-19: The Impact on Biotech